Literature DB >> 22411317

Caveolins and caveolae, roles in insulin signalling and diabetes.

Peter Strålfors1.   

Abstract

Much data in the scientific literature demonstrate a fundamental involvement of caveolae in insulin action, although particular aspects remain matters of debate. The insulin receptor and part of the downstream signalling mediators are localized in or recruited to caveolae. Moreover, as part of the signalling, insulin receptors are rapidly endocytosed by caveolae in response to the hormone. The insulin regulated glucose transporter GLUT4 appears to localize to caveolae after insulin-stimulated translocation to the plasma membrane, while the endocytosis of GLUT4 may involve a clathrin-mediated process. Insulin resistance due to dysfunction of insulin signalling in target tissues is a primary cornerstone of Type 2 diabetes. Lack of caveolae makes animals and human beings insulin resistant, but there is presently no evidence that caveolae play a role in the pathogenesis of insulin resistance in obesity and Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411317     DOI: 10.1007/978-1-4614-1222-9_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  23 in total

Review 1.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

2.  Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting.

Authors:  Helene Bayer; Katharina Essig; Sven Stanzel; Martin Frank; Jeffrey C Gildersleeve; Martin R Berger; Cristina Voss
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

Review 3.  Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

4.  Reconstitution of Torso signaling in cultured cells suggests a role for both Trunk and Torso-like in receptor activation.

Authors:  Smita Amarnath; Leslie M Stevens; David S Stein
Journal:  Development       Date:  2017-01-13       Impact factor: 6.868

5.  Affinity-Guided Design of Caveolin-1 Ligands for Deoligomerization.

Authors:  Amanda J H Gilliam; Joshua N Smith; Dylan Flather; Kevin M Johnston; Andrew M Gansmiller; Dmitry A Fishman; Joshua M Edgar; Mark Balk; Sudipta Majumdar; Gregory A Weiss
Journal:  J Med Chem       Date:  2016-04-11       Impact factor: 7.446

6.  Decreased Expression of Caveolin-1 Contributes to the Pathogenesis of Psoriasiform Dermatitis in Mice.

Authors:  Yukie Yamaguchi; Yuko Watanabe; Tomoya Watanabe; Noriko Komitsu; Michiko Aihara
Journal:  J Invest Dermatol       Date:  2015-07-02       Impact factor: 8.551

7.  Mutual regulation between IGF-1R and IGFBP-3 in human corneal epithelial cells.

Authors:  Rossella Titone; Meifang Zhu; Danielle M Robertson
Journal:  J Cell Physiol       Date:  2018-08-05       Impact factor: 6.384

Review 8.  Emerging roles of the myocardin family of proteins in lipid and glucose metabolism.

Authors:  Karl Swärd; Karin G Stenkula; Catarina Rippe; Azra Alajbegovic; Maria F Gomez; Sebastian Albinsson
Journal:  J Physiol       Date:  2016-05-10       Impact factor: 5.182

9.  Caveolae regulate vasoconstriction of conduit arteries to angiotensin II in hindlimb unweighted rats.

Authors:  Zhongchao Wang; Yungang Bai; Jinwen Yu; Huan Liu; Yaoping Cheng; Yonghong Liu; Xiaoping Xie; Jin Ma; Junxiang Bao
Journal:  J Physiol       Date:  2015-09-10       Impact factor: 5.182

10.  The long coiled-coil protein NECC2 is associated to caveolae and modulates NGF/TrkA signaling in PC12 cells [corrected].

Authors:  Alberto Díaz-Ruiz; Yoana Rabanal-Ruiz; Andrés Trávez; Francisco Gracia-Navarro; David Cruz-García; Maité Montero-Hadjadje; Youssef Anouar; Stéphane Gasman; Nicolas Vitale; Rafael Vázquez-Martínez; María M Malagón
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.